Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FB897
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,628
Award facts
- Contract value 100% obligated
- $14,627.73 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,627.73 delivery order (Contract No. 4570303654) to AmerisourceBergen Drug Corp on December 16, 2025, with an ultimate completion date of the same day. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor for federal medical procurement, with primary performance of this delivery order taking place at the company's Conshohocken location.
Under this delivery order, AmerisourceBergen supplies pharmaceutical products and medical supplies to support Defense Health Agency and federal military healthcare systems. The company's broader pharmaceutical support vehicle encompasses a comprehensive range of brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management pharmaceuticals, and antibiotics. As a child contract under the prime IDC, this delivery order demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through its established relationship with the DLA, which is planning to expand the Pharmaceutical Prime Vendor Global Program with potential multiple awards across separate regions.
Quick answers
Who was awarded contract SPE2DU26FB897?
SPE2DU26FB897 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DU26FB897 worth?
The government has obligated $14,628 on SPE2DU26FB897.
Is contract SPE2DU26FB897 an order under another contract?
Yes. SPE2DU26FB897 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FB897 competed?
The extent of competition for SPE2DU26FB897 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award